Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with PH-ILD.
Epistemonikos ID: 9b906530a4be6b94f642e5f7801fdc31de6d85f8
First added on: Sep 18, 2025